Brief: Victory Square Provides Update On Hydreight And Healthcare Investments Following FDA Advisory Committee Recommendations On Peptide-Related Bulk Drug Substances
29/07/2026 13:10
BRIEF-Victory Square Provides Update On Hydreight And Healthcare Investments Following FDA Advisory Committee Recommendations On Peptide-Related Bulk Drug Substances July 29 (Reuters) - Victory Square Technologies Inc VST.CD:
VICTORY SQUARE PROVIDES UPDATE ON HYDREIGHT AND HEALTHCARE INVESTMENTS FOLLOWING FDA ADVISORY COMMITTEE RECOMMENDATIONS ON PEPTIDE-RELATED BULK DRUG SUBSTANCES
Source text: ID:nPn5SM2cza
Further company coverage: VST.CD
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Victory Square Technologies
See all newsCanada's Victory Square Q2 revenue jumps on Hydreight strength
Brief: Victory Square Provides Update On Hydreight And Healthcare Investments Following FDA Advisory Committee Recommendations On Peptide-Related Bulk Drug Substances
Brief: Victory Square Provides Update On Hydreight And Healthcare Investments Following FDA Advisory Committee Recommendations On Peptide-Related Bulk Drug Substances
Brief: Victory Square Technologies Declares Special Common Share Dividend Of Its Interest In Yocale.ai
Brief: Hydreight Technologies Signs Binding Letter Of Intent To Acquire Dynamic Iv Therapy Support Ai Agent